Compare Mutual Funds

Pros
Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

-

INDMoney rank
6/8
1/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

13 Years 4 Months

13 Years 4 Months

Fund AUM

₹8306 Cr

₹4077 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹5000
  1. SIP ₹500
  2. Lumpsum ₹5000
Expense Ratio

0.93%

0.92%

Exit Load

1%

0.5%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

39

36

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(12.67%)
  2. Lupin Ltd(7.88%)
  3. Divi's Laboratories Ltd(6.54%)
  4. Dr Reddy's Laboratories Ltd(6.06%)
  5. Cipla Ltd(5.88%)
  1. Sun Pharmaceuticals Industries Ltd(10.02%)
  2. Divi's Laboratories Ltd(6.96%)
  3. Apollo Hospitals Enterprise Ltd(5.46%)
  4. Max Healthcare Institute Ltd Ordinary Shares(5.01%)
  5. Lupin Ltd(4.73%)
No of Sectors

1

3

Top 3 Sectors

Health

(100%)

  1. Health(91.71%)
  2. Basic Materials(8.29%)
  3. Government(5.17%)
Equity %

98.97%

98.55%

Debt %

-

0.08%

P/E

35.73

46.84

P/B

5.7

6.78

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

0.98%

1.41%

3-Month Return

0.64%

1.26%

6-Month Return

-0.08%

-0.97%

1-Year Return

11.7%

9.83%

3-Year Return

25.5%

27.32%

5-Year Return

16.61%

18.26%

Sharpe

1.17

1.35

Alpha

0.22

2.77

Beta

0.9

0.86

Standard Deviation

15.21

14.35

Information Ratio

-0.47

0.08

Description

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

SBI Healthcare Opportunities Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Sailesh Raj Bhan, Kinjal Desai, Divya Sharma, Lokesh Maru

Tanmaya Desai

Most Popular Comparisons